Coverage at a glance
| Indication | Coverage |
|---|---|
| Wegovy for cardiovascular risk reduction (SELECT indication) | Covered with PA |
| Zepbound for obstructive sleep apnea (SURMOUNT-OSA indication) | Covered with PA |
| Type 2 diabetes | Covered with PA |
Plan type: Medicare Advantage Part D and Medicare Part D. Each indication below lists the BMI and clinical thresholds, the prior-authorization documentation, and the published policy it comes from.
Coverage by indication
| BMI threshold | BMI 27 or higher |
| Cardiovascular criteria | Established cardiovascular disease per the SELECT trial criteria |
What the prior authorization needs:
- Wegovy must appear on the specific plan's drug list
- Prior authorization with established cardiovascular disease documentation
- Not covered for weight loss alone under the Medicare statute
Source: Wellcare, Does Medicare Cover Weight-Loss Drugs? Understanding GLP-1 Coverage in 2026. Official payer member resource page (HTML, fetched directly). Verified June 12, 2026.
| BMI threshold | BMI 30 or higher |
| Sleep study (AHI) | Moderate to severe OSA, AHI 15 or higher per SURMOUNT-OSA criteria |
What the prior authorization needs:
- Zepbound must appear on the specific plan's drug list
- Prior authorization with OSA diagnosis documentation
- Not covered for weight loss alone under the Medicare statute
Source: Wellcare, Does Medicare Cover Weight-Loss Drugs? Understanding GLP-1 Coverage in 2026. Official payer member resource page (HTML, fetched directly). Verified June 12, 2026.
Standard Medicare Part D type 2 diabetes GLP-1 coverage for Ozempic, Mounjaro, and Trulicity. This is not subject to the obesity exclusion.
What the prior authorization needs:
- Type 2 diabetes diagnosis
- The drug must appear on the plan's formulary
- Prior authorization with A1c and diabetes documentation
Source: Wellcare, Does Medicare Cover Weight-Loss Drugs? Understanding GLP-1 Coverage in 2026. Official payer member resource page (HTML, fetched directly). Verified June 12, 2026.
Formulary note: Coverage requires the drug to appear on your individual plan's drug list. The Medicare GLP-1 Bridge starting July 2026 will add a $50 per month pathway for eligible Part D beneficiaries.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list, then have your prescriber submit it.
- Start with the Wellcare Medicare prior-authorization letter template, which cites this plan's policy and the diagnosis codes a reviewer looks for. Pick the indication that matches your clinical picture.
- Read the full coverage picture, denial reasons, and the four appeal pathways at GLP-1 insurance coverage.
- If your plan does not cover the indication you need, compare cash-pay options in the cost guide and the cheapest legitimate programs.
Frequently asked questions
Does Wellcare Medicare cover GLP-1 medications?
It depends on the indication. Wellcare Medicare cannot cover GLP-1s for weight loss alone, under the Medicare statute. It covers Wegovy for cardiovascular risk, Zepbound for sleep apnea, and the diabetes brands for type 2 diabetes, when the drug is on your plan's formulary. This reflects the published policy verified June 2026.
What does Wellcare Medicare require to approve GLP-1 medications?
For wegovy for cardiovascular risk reduction (SELECT indication): The BMI requirement is BMI 27 or higher.
Is GLP-1 medications covered for weight loss under Wellcare Medicare?
Coverage depends on the indication. Weight loss alone may be excluded while a related medical indication is covered. Each indication and its rule are listed above with the source.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Each page is built from a published payer policy document, government statute, or independent formulary analysis (KFF). Every indication row carries the source URL and the date we verified it. Where a payer's policy PDF was confirmed at its public URL but served as an unreadable binary, the policy number and coverage framework were cross-checked against secondary sources and the row is marked lower confidence. Commercial coverage often depends on whether an employer elected the weight-management benefit, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
